Combinations of Anti-LFA-1, Everolimus, Anti-CD40 Ligand, and Allogeneic Bone Marrow Induce Central Transplantation Tolerance through Hemopoietic Chimerism, Including Protection from Chronic Heart Allograft Rejection-Reference-Cited by-同舟云学术

Combinations of Anti-LFA-1, Everolimus, Anti-CD40 Ligand, and Allogeneic Bone Marrow Induce Central Transplantation Tolerance through Hemopoietic Chimerism, Including Protection from Chronic Heart Allograft Rejection

Published:2004-11-19 Issue:11 Volume:173 Page:7025-7036
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Metzler Barbara,Gfeller Patrick,Bigaud Marc,Li Jianping,Wieczorek Grazyna,Heusser Christoph,Lake Philip,Katopodis Andreas

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference72 articles.

1. Allogeneic hematopoietic stem cell transplantation—Yesterday, today, and tomorrow

2. Non-myeloablative hematopoietic cell transplantation as immunotherapy for hematologic malignancies

3. MECHANISMS OF ACQUIRED THYMIC UNRESPONSIVENESS TO RENAL ALLOGRAFTS

4. Tolerance Induction for Solid Organ Grafts with Donor-Derived Hematopoietic Reconstitution

5. Mixed Chimerism and Transplantation Tolerance

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thalidomide with blockade of co-stimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts;BMC Immunology;2020-04-16

2. Blockade of adhesion molecule lymphocyte function–associated antigen-1 improves long-term heart allograft survival in mixed chimeras;The Journal of Heart and Lung Transplantation;2018-09

3. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade;Transplant Immunology;2015-03

4. Future Pathways for Immune Manipulation;Textbook of Organ Transplantation;2014-07-25

5. Anti-LFA-1 or rapamycin overcome costimulation blockade-resistant rejection in sensitized bone marrow recipients;Transplant International;2012-12-13